Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Collegium Pharmaceutical (COLL) Other Non-Current Liabilities (2016 - 2025)

Collegium Pharmaceutical has reported Other Non-Current Liabilities over the past 6 years, most recently at $19000.0 for Q3 2025.

For Q3 2025, Other Non-Current Liabilities fell 99.54% year-over-year to $19000.0; the TTM value through Sep 2025 reached $19000.0, down 99.54%, while the annual FY2024 figure was $1.2 million, N/A changed from the prior year.
Other Non-Current Liabilities for Q3 2025 was $19000.0 at Collegium Pharmaceutical, down from $38000.0 in the prior quarter.
Over five years, Other Non-Current Liabilities peaked at $4.1 million in Q3 2024 and troughed at $19000.0 in Q3 2025.